Literature DB >> 1807540

Fetal outcome following intrauterine amantadine exposure.

M Levy1, A Pastuszak, G Koren.   

Abstract

Amantadine hydrochloride is a well-known antiviral agent that has been used for the prevention of influenza A2, the treatment of Parkinson disease, and, more recently, multiple sclerosis. However, very few data exist about its use in pregnant women. We report a 34-year-old woman who had used amantadine to prevent relapse of her multiple sclerosis throughout two of her pregnancies who subsequently delivered two normal infants. We review the available animal data and two other human pregnancy exposure reports.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1807540     DOI: 10.1016/0890-6238(91)90114-u

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  3 in total

1.  Reply to Comment on: Management of Parkinson's Disease During Pregnancy.

Authors:  Caitlin Young; Kathryn J Peall
Journal:  Mov Disord Clin Pract       Date:  2020-08-24

2.  Use of anti-Parkinson medication during pregnancy: a case series.

Authors:  Zeynep Tüfekçioğlu; Haşmet Hanağası; Gül Yalçın Çakmaklı; Bülent Elibol; Figen Esmeli Tokuçoğlu; Zeynep Ece Kaya; Sibel Ertan; Sibel Özekmekçi; Murat Emre
Journal:  J Neurol       Date:  2018-06-20       Impact factor: 4.849

Review 3.  Treatment of community-acquired lower respiratory tract infections during pregnancy.

Authors:  Wei Shen Lim; John T Macfarlane; Charlotte L Colthorpe
Journal:  Am J Respir Med       Date:  2003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.